NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NVCR NovoCure Limited

交易中 12-15 11:33:37 EST

13.17

-0.15

-1.16%

最高13.49	最低13.10	成交量19.18万
今开13.42	昨收13.32	日振幅2.93%
总市值14.74亿	流通市值12.39亿	总股本1.12亿
成交额254.61万	换手率0.20%	流通股本9,415万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"NVCR","market":"US","secType":"STK","nameCN":"NovoCure Limited","latestPrice":13.165,"timestamp":1765816417430,"preClose":13.32,"halted":0,"volume":191837,"delay":0,"floatShares":94147892,"shares":111981981,"eps":-1.60741,"marketStatus":"交易中","change":-0.155,"latestTime":"12-15 11:33:37 EST","open":13.42,"high":13.49,"low":13.1,"amount":2546079.272189,"amplitude":0.029279,"askPrice":13.17,"askSize":2,"bidPrice":13.16,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-1.60741,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765832400000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1443758400000,"exchange":"NASDAQ","adjPreClose":13.32,"preHourTrading":{"tag":"盘前","latestPrice":13.35,"preClose":13.32,"latestTime":"08:47 EST","volume":78,"amount":1042.54995,"timestamp":1765806434163},"postHourTrading":{"tag":"盘后","latestPrice":13.32,"preClose":13.32,"latestTime":"18:49 EST","volume":949165,"amount":12642902.698,"timestamp":1765583368341},"volumeRatio":0.332293,"impliedVol":0.6165,"impliedVolPercentile":0.52},"requestUrl":"/m/hq/s/NVCR/wiki","defaultTab":"wiki","newsList":[{"id":"2577864985","title":"Novocure Limited盘中异动 股价大涨5.15%报14.49美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2577864985","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577864985?lang=zh_cn&edition=full","pubTime":"2025-10-20 21:43","pubTimestamp":1760967797,"startTime":"0","endTime":"0","summary":"北京时间2025年10月20日21时43分，Novocure Limited股票出现波动，股价急速上涨5.15%。截至发稿，该股报14.49美元/股，成交量8.0823万股，换手率0.07%，振幅2.98%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.63%。其相关个股中，Quantum-Si Incorporated、Dih Holding Us, Inc.、Butterfly Network, Inc.涨幅较大，Sintx Technologies, Inc.、Invo Fertility, Inc.、迪卡斯较为活跃，换手率分别为185.09%、23.16%、3.40%，振幅较大的相关个股有Dih Holdings Us Inc C/Wts 20/04/2028 、Sintx Technologies, Inc.、Perspective Therapeutics, Inc.，振幅分别为21.17%、13.89%、11.58%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021431894d3f51d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102021431894d3f51d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","NVCR","BK4585","BK4082","BK4534","BK4548"],"gpt_icon":0},{"id":"2574948038","title":"Novocure Limited盘中异动 股价大跌5.09%报13.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2574948038","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2574948038?lang=zh_cn&edition=full","pubTime":"2025-10-10 23:28","pubTimestamp":1760110137,"startTime":"0","endTime":"0","summary":"北京时间2025年10月10日23时28分，Novocure Limited股票出现波动，股价快速下挫5.09%。截至发稿，该股报13.60美元/股，成交量28.9338万股，换手率0.26%，振幅5.79%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.31%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023285894c2111d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025101023285894c2111d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR","BK4588","BK4082","BK4534","BK4585","BK4548"],"gpt_icon":0},{"id":"1108413401","title":"NovoCure将在2025年ASTRO年会上公布关键3期METIS临床试验最终结果，该试验评估肿瘤电场治疗技术治疗非小细胞肺癌脑转移瘤的疗效","url":"https://stock-news.laohu8.com/highlight/detail?id=1108413401","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108413401?lang=zh_cn&edition=full","pubTime":"2025-09-30 04:30","pubTimestamp":1759177833,"startTime":"0","endTime":"0","summary":"NovoCure将在2025年ASTRO年会上公布其关键3期METIS临床试验的最终结果，该试验评估了肿瘤电场治疗技术（TTFields）用于治疗非小细胞肺癌脑转移瘤的疗效。\n这项重要的3期临床试验旨在验证肿瘤电场治疗技术在治疗非小细胞肺癌脑转移瘤患者中的临床应用价值。此次在ASTRO年会上的数据展示将为医疗界提供关于该创新疗法最新临床证据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4534","BK4585","NVCR","BK4548","BK4082"],"gpt_icon":0},{"id":"1164578861","title":"NovoCure的Optune Lua®在日本获批用于治疗不可切除的晚期/复发性非小细胞肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1164578861","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164578861?lang=zh_cn&edition=full","pubTime":"2025-09-15 19:01","pubTimestamp":1757934086,"startTime":"0","endTime":"0","summary":"NovoCure的Optune Lua®在日本获得监管批准，用于治疗不可切除的晚期/复发性非小细胞肺癌。\n这一批准标志着该创新治疗设备在日本市场的重要进展，为当地非小细胞肺癌患者提供了新的治疗选择。Optune Lua®是专门针对不可切除的晚期或复发性非小细胞肺癌患者设计的治疗方案。\n此次在日本获得批准，进一步扩大了NovoCure在亚洲市场的治疗覆盖范围，为更多肺癌患者带来希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4534","BK4588","BK4585","NVCR","BK4548"],"gpt_icon":0},{"id":"2562756956","title":"Novocure Limited盘中异动 下午盘股价大跌5.07%报11.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2562756956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2562756956?lang=zh_cn&edition=full","pubTime":"2025-08-26 01:41","pubTimestamp":1756143699,"startTime":"0","endTime":"0","summary":"北京时间2025年08月26日01时41分，Novocure Limited股票出现波动，股价急速跳水5.07%。截至发稿，该股报11.80美元/股，成交量52.7398万股，换手率0.47%，振幅4.83%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.42%。其相关个股中，Icecure Medical Ltd.、Shoulder Innovations, Inc.、Nanovibronix, Inc.涨幅较大，Aethlon Medical, Inc.、Bluejay Diagnostics, Inc.、Invo Fertility, Inc.较为活跃，换手率分别为48.33%、22.58%、21.54%，振幅较大的相关个股有Heartsciences Inc C/Wts 、Dih Holdings Us Inc C/Wts 20/04/2028 、Nexalin Technology Inc C/Wts ，振幅分别为43.27%、39.04%、29.18%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826014139a6faef39&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250826014139a6faef39&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4534","NVCR","BK4588","BK4585","BK4082"],"gpt_icon":0},{"id":"1108375975","title":"NovoCure Limited宣布西班牙将为新诊断胶质母细胞瘤患者提供肿瘤电场治疗(TTFields)保险覆盖","url":"https://stock-news.laohu8.com/highlight/detail?id=1108375975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108375975?lang=zh_cn&edition=full","pubTime":"2025-08-25 19:01","pubTimestamp":1756119676,"startTime":"0","endTime":"0","summary":"NovoCure Limited宣布，西班牙将为新诊断胶质母细胞瘤患者提供肿瘤电场治疗(TTFields)疗法的保险覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4548","BK4588","BK4534","BK4585","BK4082","NVCR"],"gpt_icon":0},{"id":"2555834311","title":"Novocure Limited盘中异动 早盘股价大涨5.01%报11.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555834311","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555834311?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:31","pubTimestamp":1753968697,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时31分，Novocure Limited股票出现波动，股价急速上涨5.01%。截至发稿，该股报11.52美元/股，成交量17.3003万股，换手率0.15%，振幅2.28%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.56%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121313894c66093&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025073121313894c66093&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4585","BK4082","NVCR","BK4588","BK4534"],"gpt_icon":0},{"id":"2554599796","title":"Novocure Limited2025财年第二财季实现净利润-40.14百万美元，同比减少20.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2554599796","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554599796?lang=zh_cn&edition=full","pubTime":"2025-07-26 00:00","pubTimestamp":1753459251,"startTime":"0","endTime":"0","summary":"7月26日，Novocure Limited公布财报，公告显示公司2025财年第二财季净利润为-40.14百万美元，同比减少20.25%；其中营业收入为1.59亿美元，同比增加6.00%，每股基本收益为-0.36美元。从资产负债表来看，Novocure Limited总负债8.96亿美元，其中短期债务5.60亿美元，资产负债比为1.40，流动比率为1.45。机构评级：截至2025年7月26日，当前有8家机构对Novocure Limited目标价做出预测，其中目标均价为27.19美元，其中最低目标价为14.50美元，最高目标价为38.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726000057a6c20126&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726000057a6c20126&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR"],"gpt_icon":0},{"id":"2549776557","title":"Novocure Limited盘中异动 大幅跳水5.00%报16.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549776557","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549776557?lang=zh_cn&edition=full","pubTime":"2025-07-08 03:55","pubTimestamp":1751918110,"startTime":"0","endTime":"0","summary":"北京时间2025年07月08日03时55分，Novocure Limited股票出现异动，股价大幅下跌5.00%。截至发稿，该股报16.83美元/股，成交量46.3343万股，换手率0.42%，振幅5.82%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.96%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708035510979d64ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708035510979d64ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4534","BK4548","BK4585","BK4082","NVCR"],"gpt_icon":0},{"id":"2546947729","title":"Novocure Limited盘中异动 临近收盘快速拉升5.03%报17.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546947729","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546947729?lang=zh_cn&edition=full","pubTime":"2025-06-28 03:57","pubTimestamp":1751054269,"startTime":"0","endTime":"0","summary":"北京时间2025年06月28日03时57分，Novocure Limited股票出现波动，股价大幅拉升5.03%。截至发稿，该股报17.96美元/股，成交量159.654万股，换手率1.43%，振幅5.44%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.81%。其相关个股中，Autonomix Medical, Inc.、Nexalin Technology Inc C/Wts 、Sera Prognostics, Inc.涨幅较大，Bone Biologics Corp、Autonomix Medical, Inc.、Nanovibronix, Inc.较为活跃，换手率分别为4847.41%、1481.42%、1403.70%，振幅较大的相关个股有Autonomix Medical, Inc.、Sera Prognostics, Inc.、Nexalin Technology Inc C/Wts ，振幅分别为91.97%、50.50%、42.20%。Novocure Limited公司简介：NovoCure Ltd 是一家在美国拥有专有平台技术的肿瘤公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035749952e7b1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250628035749952e7b1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4534","BK4548","BK4585","BK4082","NVCR"],"gpt_icon":0},{"id":"2517162511","title":"Novocure Limited2024财年实现净利润-1.69亿美元，同比增加18.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517162511","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517162511?lang=zh_cn&edition=full","pubTime":"2025-03-07 00:01","pubTimestamp":1741276872,"startTime":"0","endTime":"0","summary":"3月7日，Novocure Limited公布财报，公告显示公司2024财年净利润为-1.69亿美元，同比增加18.36%；其中营业收入为6.05亿美元，同比增加18.86%，每股基本收益为-1.56美元。从资产负债表来看，Novocure Limited总负债8.81亿美元，其中短期债务5.66亿美元，资产负债比为1.41，流动比率为1.47。机构评级：截至2025年3月7日，当前有7家机构对Novocure Limited目标价做出预测，其中目标均价为35.57美元，其中最低目标价为29.00美元，最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000141a262a624&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307000141a262a624&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR"],"gpt_icon":0},{"id":"2517237919","title":"Novocure Limited盘中异动 下午盘股价大涨5.06%报19.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517237919","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517237919?lang=zh_cn&edition=full","pubTime":"2025-03-06 03:08","pubTimestamp":1741201686,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日03时08分，Novocure Limited股票出现波动，股价快速拉升5.06%。截至发稿，该股报19.11美元/股，成交量47.8953万股，换手率0.44%，振幅7.61%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为1.27%。其相关个股中，Xylo Technologies Ltd、Trisalus Life Sciences Inc C/Wts 10/08/28 、Intelligent Bio Solutions Inc.涨幅较大，古特拉、908 Devices Inc.、Tivic Health Systems, Inc.较为活跃，换手率分别为68.84%、30.64%、10.63%，振幅较大的相关个股有Pavmed Inc C/Wts 30/04/2025 Class Z、Ainos, Inc.、Heartsciences Inc.，振幅分别为40.00%、34.75%、23.28%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030806a2611461&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306030806a2611461&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4534","BK4585","BK4548","NVCR","BK4588","BK4082"],"gpt_icon":0},{"id":"2516212668","title":"Novocure Limited盘中异动 下午盘大幅跳水5.03%报18.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516212668","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516212668?lang=zh_cn&edition=full","pubTime":"2025-03-04 04:20","pubTimestamp":1741033217,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日04时20分，Novocure Limited股票出现波动，股价快速下挫5.03%。截至发稿，该股报18.11美元/股，成交量65.9658万股，换手率0.60%，振幅4.93%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.80%。其相关个股中，Adagio Medical Holdings, Inc、Senseonics Holdings, Inc.、Ceribell, Inc.涨幅较大，Reshape Lifesciences, Inc.、Sintx Technologies, Inc.、Bluejay Diagnostics, Inc.较为活跃，换手率分别为49.97%、18.47%、12.78%，振幅较大的相关个股有Nexalin Technology Inc C/Wts 、Ainos Inc C/Wts 29/07/2027 、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为71.96%、59.09%、40.86%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042017abe693de&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304042017abe693de&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NVCR","BK4588","BK4082","BK4548","BK4585","BK4534"],"gpt_icon":0},{"id":"2514320023","title":"Novocure Limited盘中异动 早盘股价大跌5.30%报18.21美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514320023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514320023?lang=zh_cn&edition=full","pubTime":"2025-02-28 22:34","pubTimestamp":1740753254,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日22时34分，Novocure Limited股票出现异动，股价急速下挫5.30%。截至发稿，该股报18.21美元/股，成交量4.6598万股，换手率0.04%，振幅3.28%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.60%。其相关个股中，Monogram Technologies Inc.、Intelligent Bio Solutions Inc.、Heartsciences Inc.涨幅较大，Rapid Micro Biosystems, Inc.、Dih Holding Us, Inc.、沃氪医疗较为活跃，换手率分别为14.97%、3.98%、2.36%，振幅较大的相关个股有Envveno Medical Corporation、Butterfly Network, Inc.、Ainos, Inc.，振幅分别为16.15%、10.19%、8.94%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223414abe0eb6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228223414abe0eb6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4534","BK4548","BK4585","BK4082","NVCR"],"gpt_icon":0},{"id":"1166495530","title":"异动解读 | NovoCure 2024年Q4净亏损超预期 股价盘中大跌8.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166495530","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166495530?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:45","pubTimestamp":1740667507,"startTime":"0","endTime":"0","summary":"NovoCure Limited(纳斯达克代码:NVCR)今日盘中大跌8.38%,引发了市场广泛关注。\n\n公司2024年第四季度财报显示,尽管该季度营收1.61亿美元高于市场预期的1.58亿美元,但每股净亏损为0.61美元,却大幅超出分析师共识预期的0.34美元亏损水平。\n\n净亏损数据遭超预期,显然令投资者失望,这可能是导致NovoCure股价盘中大幅震荡下跌的主要原因。市场对公司盈利能力存疑,在此前景不佳的财报出炉后,投资者或选择先行减持股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["NVCR"],"gpt_icon":0},{"id":"2514628385","title":"Novocure Limited盘中异动 早盘股价大跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514628385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514628385?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:32","pubTimestamp":1740666737,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时32分，Novocure Limited股票出现波动，股价急速下挫5.10%。截至发稿，该股报20.84美元/股，成交量3.9549万股，换手率0.04%，振幅4.87%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.03%。其相关个股中，Dih Holdings Us Inc C/Wts 20/04/2028 、Biomerica, Inc.、Establishment Labs Holdings Inc.涨幅较大，Bone Biologics Corp、Reshape Lifesciences, Inc.、Tandem Diabetes Care, Inc.较为活跃，换手率分别为3.37%、2.68%、1.11%，振幅较大的相关个股有Beyond Air, Inc.、Tandem Diabetes Care, Inc.、Standard Biotools Inc.，振幅分别为16.76%、9.59%、8.55%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223217abdf6ec8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227223217abdf6ec8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4588","BK4534","BK4548","BK4585","BK4082","NVCR"],"gpt_icon":0},{"id":"1198797301","title":"NovoCure 2024年第四季度GAAP每股收益$(0.61)不及预期$(0.34)，销售额$1.6127亿高于预期$1.5781亿","url":"https://stock-news.laohu8.com/highlight/detail?id=1198797301","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1198797301?lang=zh_cn&edition=full","pubTime":"2025-02-27 20:10","pubTimestamp":1740658225,"startTime":"0","endTime":"0","summary":"NovoCure  报告称季度每股亏损$，未达到分析师共识预期的$，差79.41%。这比去年同期每股亏损$下降了35.56%。公司报告季度销售额为1.6127亿美元，高于分析师共识预期的1.5781亿美元，增长2.19%。以上内容来自Benzinga Earnings专栏，原文如下：NovoCure  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 79.41 percent. This is a 35.56 percent decrease over losses of $ per share from the same period last year.  The company reported quarterly sales of $161.27 million which beat the analyst consensus estimate of $157.81 million by 2.19 percent.  This is a 20","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NovoCure 2024年第四季度GAAP每股收益$(0.61)不及预期$(0.34)，销售额$1.6127亿高于预期$1.5781亿","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVCR"],"gpt_icon":0},{"id":"2514859851","title":"Novocure Limited盘中异动 早盘大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859851","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514859851?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:04","pubTimestamp":1740582267,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时04分，Novocure Limited股票出现异动，股价快速拉升5.00%。截至发稿，该股报22.05美元/股，成交量12.8599万股，换手率0.12%，振幅4.59%。Novocure Limited股票所在的医疗器械行业中，整体涨幅为0.55%。其相关个股中，Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 、沃氪医疗、麦斯莫医疗涨幅较大，Venus Concept Inc.、Sintx Technologies, Inc.、Biomerica, Inc.较为活跃，换手率分别为12.47%、11.59%、10.38%，振幅较大的相关个股有Inogen, Inc、Rapid Micro Biosystems, Inc.、Inspira Tech Oxy Bhn Ltd C/Wts 16/07/2026 ，振幅分别为33.09%、18.09%、17.14%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230427963155fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226230427963155fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4534","NVCR","BK4588","BK4585","BK4082"],"gpt_icon":0},{"id":"2511661596","title":"Novocure Limited盘中异动 快速拉升5.67%报22.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511661596?lang=zh_cn&edition=full","pubTime":"2025-02-15 01:50","pubTimestamp":1739555451,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日01时50分，Novocure Limited股票出现异动，股价急速拉升5.67%。截至发稿，该股报22.94美元/股，成交量32.9524万股，换手率0.30%，振幅4.84%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.38%。其相关个股中，Avita Medical, Inc.、Pacific Biosciences Of California, Inc.、Envoy Medical Inc C/Wts 29/09/2028 涨幅较大，Nanovibronix, Inc.、Tivic Health Systems, Inc.、Nano-X Imaging Ltd较为活跃，换手率分别为221.08%、66.42%、12.93%，振幅较大的相关个股有Dih Holdings Us Inc C/Wts 20/04/2028 、Nanovibronix, Inc.、Nexalin Technology Inc C/Wts ，振幅分别为75.00%、62.27%、44.63%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015051a2462bc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215015051a2462bc8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4588","NVCR","BK4548","BK4534","BK4585"],"gpt_icon":0},{"id":"2509878392","title":"Novocure Limited盘中异动 大幅下挫5.05%报22.96美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509878392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509878392?lang=zh_cn&edition=full","pubTime":"2025-02-07 03:33","pubTimestamp":1738870433,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日03时33分，Novocure Limited股票出现异动，股价大幅下挫5.05%。截至发稿，该股报22.96美元/股，成交量49.7615万股，换手率0.46%，振幅5.00%。Novocure Limited股票所在的医疗器械行业中，整体跌幅为0.71%。其相关个股中，Trisalus Life Sciences Inc C/Wts 10/08/28 、Nevro Corp.、Nanovibronix, Inc.涨幅较大，Nevro Corp.、Nanovibronix, Inc.、Sensus Healthcare, Inc.较为活跃，换手率分别为27.39%、22.96%、14.83%，振幅较大的相关个股有Nanovibronix, Inc.、Tenon Medical Inc C/Wts 16/06/2028 、Hyperfine, Inc.，振幅分别为32.16%、30.81%、30.25%。Novocure Limited公司简介：NovoCure Ltd服务于美国的医疗保健行业。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033355961a4476&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207033355961a4476&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4585","BK4082","NVCR","BK4588","BK4534"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.novocure.com","stockEarnings":[{"period":"1week","weight":0.0999},{"period":"1month","weight":0.1725},{"period":"3month","weight":0.0963},{"period":"6month","weight":-0.241},{"period":"1year","weight":-0.5569},{"period":"ytd","weight":-0.553}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Novocure Limited是一家公共有限责任公司，于2000年2月11日在泽西岛海峡群岛法律下注册成立。该公司是一家商用的抗肿瘤公司，开发了一种新的专有的疗法被称为肿瘤治疗领域，或TTFields，用来对抗实体瘤癌症。","yearOnYearQuotes":[{"month":1,"riseRate":0.3,"avgChangeRate":-0.024854},{"month":2,"riseRate":0.4,"avgChangeRate":-0.01214},{"month":3,"riseRate":0.5,"avgChangeRate":-0.017692},{"month":4,"riseRate":0.5,"avgChangeRate":0.079553},{"month":5,"riseRate":0.8,"avgChangeRate":0.134604},{"month":6,"riseRate":0.4,"avgChangeRate":-0.026837},{"month":7,"riseRate":0.5,"avgChangeRate":-0.004605},{"month":8,"riseRate":0.6,"avgChangeRate":0.019977},{"month":9,"riseRate":0.4,"avgChangeRate":-0.021376},{"month":10,"riseRate":0.2,"avgChangeRate":-0.091688},{"month":11,"riseRate":0.636364,"avgChangeRate":0.077306},{"month":12,"riseRate":0.545455,"avgChangeRate":0.067946}],"exchange":"NASDAQ","name":"NovoCure Limited","nameEN":"NovoCure"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NovoCure Limited(NVCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NovoCure Limited,NVCR,NovoCure Limited股票,NovoCure Limited股票老虎,NovoCure Limited股票老虎国际,NovoCure Limited行情,NovoCure Limited股票行情,NovoCure Limited股价,NovoCure Limited股市,NovoCure Limited股票价格,NovoCure Limited股票交易,NovoCure Limited股票购买,NovoCure Limited股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NovoCure Limited(NVCR)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NovoCure Limited(NVCR)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}